Noble Life Sciences, Inc.

Sykesville, MD

UEI
KNWJNY921X93
CAGE
64VA2
Primary NAICS
541380 Testing Laboratories and Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Founded
2010
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

SBA capabilities narrative

Noble Life Sciences provides integrated GLP and non-GLP preclinical services designed to accelerate development for drugs, vaccines and medical devices. Services include pharmacology, disease models, early safety assessments, toxicology, biomarker validation and tumor profiling, and analytical testing. We are committed to providing a strong scientific foundation to enable your preclinical decisions.

Quick answers

Is Noble Life Sciences, Inc. registered in SAM.gov?

Yes. Noble Life Sciences, Inc.'s SAM.gov registration is active through May 12, 2027.

What is Noble Life Sciences, Inc.'s CAGE code?

Noble Life Sciences, Inc.'s CAGE code is 64VA2, and its Unique Entity ID (UEI) is KNWJNY921X93.

What is Noble Life Sciences, Inc.'s most recent federal award?

Noble Life Sciences, Inc.'s most recent federal contract award is PK/PD study of pyridostigmine bromide (W911QY20P0290), from ACC Aberdeen Proving Ground, on September 14, 2020.

On GovTribe

See Noble Life Sciences, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe